Table 3

Demographics and epidemiological features of Chlamydia trachomatis cases coinfected with Mycoplasma genitalium, compared with Neisseria gonorrhoeae cases coinfected with M. genitalium, respectively (n=56)

C . trachomatis cases with M. genitalium detected, n=27 (%, 95% CI) or mean (range) N . gonorrhoeae cases with M. genitalium detected, n=29 (%, 95% CI) or mean (range)OR (95% CI)P value*
Age32
(22–51)
30
(20–56)
0.98
(0.92 to 1.05)
0.556
Number of male sexual partners in the last 3 months
10.5
(1–100)
8.08
(1–25)
0.99
(0.95 to 1.03)
0.567
Condom use with male partners in the last 3 months
Not always24
(92, 75 to 99)
21
(84, 64 to 95)
1
Always2
(8, 1 to 25)
4
(16, 5 to 36)
2.29
(0.38 to 13.77)
0.367
Using PrEP†
No15
(56, 35 to 75)
14
(70, 46 to 88)
1
Yes12
(44, 35 to 65)
6
(30, 12 to 54)
0.25
(0.10 to 0.65)
0.002
Symptomatic‡
No19
(70, 50 to 86)
15
(52, 33 to 71)
1
Yes8
(30, 14 to 50)
14
(48, 29 to 67)
2.22
(0.74 to 6.67)
0.157
Anal symptoms§
No25
(93, 76 to 99)
24
(83, 64 to 94)
1
Yes2
(7, 1 to 24)
5
(17, 6 to 36)
2.60
(0.46 to 14.73)
0.258
STI contact
No23
(85, 66 to 96)
25
(86, 68 to 96)
1
Yes4
(15, 4 to 34)
4
(14, 4 to 32)
0.92
(0.21 to 4.11)
0.913
  • Data missing for up to 14% of condom use in gonorrhoea samples and 4% of condom use in chlamydia samples.

  • *P value calculated using logistic regression, and bold indicates significant findings.

  • †Individuals with HIV were excluded for this variable.

  • ‡Symptomatic was defined as the presence of any symptoms, including symptoms at sites other than the rectum.

  • §Anal symptoms included anal discharge, anal itch, anal pain, anal bleeding, painful bowel motions or tenesmus.

  • PrEP, HIV pre-exposure prophylaxis.